BioCentury
ARTICLE | Clinical News

Annamycin: Began Phase I/II testing

May 3, 1999 7:00 AM UTC

Aronex Pharmaceuticals Inc. (ARNX), The Woodlands, Texas Product: Annamycin Business: Cancer Therapeutic category: Adjunct Target: Topoisomerase Description: Liposomal anthracycline analog that main...